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ABSTRACT 
For the practical use to adoptive immunotherapy of cancer， peripheral blood lymphocytes 
(PBL)， regional lymph node lymphocytes (RLNL) and tumor infiltrating lymphocytes (TIL) 
from 12 lung and 13 breast cancer patients were cultured with interleukin-2(IL-2) for 20 
days. Cell numbers decreased on day5 ，and gradually increased up to 5 times as much as set 
up on day20. In PBL culture macrophages proliferated and number of lymphocytes were 
diminished in some cases. Cytotoxic activity was measured in a 4 hours 51chromium release 
assay on day5， day10 and day20. Lymphokine-activated killer (LAK) activity against target 
Daudi cel was attained on day5， but diminished on day10，then attained again on day20. PBL 
had the highest LAK activity through the culture. Cytotoxicity against autologous cancer 
cells was attained in RLNL and TIL on day20.Long-term cultured lymphocytes were tested 
for their surface marker. RLNL and TIL were comprised largely of CD3+cells. Especially 
RLNL had a large number of CD4+cells. There was no correlation between the cytotoxicity 
and the percentage of phenotype which had a surface marker tested. 
These results show that long-term culture is useful to generate large scale number of 
LAK cells， and RLNL and TIL are more effective than PBL for the effector of adoptive 
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きた2)3)4) この IL-2で活性化されたリンパ球は
















































75% Ficol1-Paque， 500 X g， 30min，室温)によ
って腫蕩細胞と MNCを分離した.腫蕩細胞は分
離洗浄後直ちにフリーザー (-800C)で凍結保存










化ヒト AB型血清， 2mM L-glutamine， 2 X 10-5 
M 2-mercaptoethanol， 200unitl ml penicil-
















plete mediumを加え， 90分間 incubator(37"C， 
5 % CO2)の中で 15分毎に撹枠しながら培養し

















り，その放射活性を garnrnacounter (Aroka， 
ARC-221 Autowell garnrna systern)で測定し
た.測定は全て triplicateで行い， % cytotoxicity 
は以下の計算式で求めた.
% cytotoxicity= 
experirnental release -spontaneous release 













使用した一次抗体は NU-T3(CD 3)， NU-
TH/I(CD 4)， NU-TS/C(CD 8)， NU-Ia(HLA 
-DR) (ニチレイ)で，二次抗体は fluorescein-
conjugated goat anti-rnouse irnrnunoglobu日n
(Becton Dickinson， USA)を用いた.
染色方法はまず 1X 106個のリンパ球に対して
10μ1の一次抗体を加え， 4 oC， 20分 incubationし
て， staining buffer (phosphate buffer saline， 














め， 1 X 106個で開始できないことがあった.それ
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14 15 7 10 12 10 






無刺激 5 10 
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岡2.末梢血リンパ球の細胞揮害活性
n=6 
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L A K活性 自家騒1喜に対する幸田胞怒1lf活性。
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イ直を示し， suppressor / cytotoxic T細胞のマーカ
ーである CD8陽性細胞の割合は PBLにおいて
は37.9土6.7%，RLNLでは23.5:12.9%と逆転を
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図6. リンパ球のsubpopulationと細胞障害活性の相関





















































































胞由来の LAK活性が誘導され， 3 -4日以降は
す細胞由来の LAK活性が誘導されてくるという
報告もある9)14) したがって本実験において 5司
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